Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

These new skin treatments are safer and more effective with minimal side effects.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Tofacitinib is effective and safe for treating severe alopecia areata.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Topical IKKα inhibitors may help prevent CCS tumours.

MK-5108 is safe and shows potential against tumors, especially alone.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.